ClinicalTrials.Veeva

Menu

Communicational Program "Trust" to Improve Adherence to Medications

M

Meshalkin Research Institute of Pathology of Circulation

Status

Unknown

Conditions

Coronary Artery Disease
Cardiovascular Diseases
Myocardial Infarction

Treatments

Other: Standard outpatient observation
Behavioral: Communicational program "Trust"

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT03268291
Call of Trust

Details and patient eligibility

About

The trial was designed in such a way as to show that the proposed program "Trust" increases the proportion of patients who adhere to therapy in the cohort of those with coronary heart disease for two years after successful revascularization by using thrombolytic or stenting of the coronary arteries against the background of myocardial infarction.

Full description

The "Trust" program includes a set of measures aimed at increasing the level of adherence to therapy in patients with myocardial infarction. Differences in adherence rates between patients enrolled in the program and patients undergoing standard outpatient care will be monitored during the study. The study will be conducted according to the clinical approbation protocol, the principles of good clinical practice (GCP) and regulatory requirements.

The developed program is based on the experience of international research studies and includes the following sections:

  • daily seminars with patients going to be discharged about the benefits of adherence to therapy; distribution of printed materials;
  • service for the regular informing of the patients which is motivating to remain adherence to medications by automated contact management systems (SMS, e-mail), as well as calls from contact center operators;
  • questioning of participants of the program for general adherence to therapy, reasons for refusal, change of therapy / drug, complaints and other. The questioning is carried out through telephone interviewing by contact center operators and automatic collection of electronic forms through aggregator services.

Information motivating to remain adherence to the therapy is structured as follows:

A) greeting and presentation, a reminder of the necessity for therapy, with the support of the patient's Trust in prolonging the quality of life by regular use of medications; B) the explanation of the action of the medicine taking into account the peculiarities of ordinary consciousness, warning the patient of the most common mistakes in treatment; C) recommendations for changing lifestyle and explaining their need; D) a reminder of the possibility to contact the attending physician, emotional support and counseling.

The establishment of an information and counseling center will allow the patient to be supported throughout the time when the likelihood of giving up therapy and the risk of complications due to failure are most likely.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed consent
  • Recent acute myocardial infarction within the past 2 months
  • Successful revascularization via coronary stenting or thrombolysis

Exclusion criteria

  • Concomitant cardiovascular disorders requiring surgical treatment
  • Coronary revascularization via CABG
  • Patient refused from participating
  • Patient is not available for communication within 2 months

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 2 patient groups

Standard outpatient observation
Active Comparator group
Description:
Outpatient management according to Ministry of health standards
Treatment:
Other: Standard outpatient observation
Communicational program "Trust"
Experimental group
Description:
The developed program is based on the experience of international research studies and includes the following sections: * daily seminars with patients going to be discharged about the benefits of adherence to therapy; distribution of printed materials; * service for the regular informing of the patients which is motivating to remain adherence to medications by automated contact management systems (SMS, e-mail), as well as calls from contact center operators; * questioning of participants of the program for general adherence to therapy, reasons for refusal, change of therapy / drug, complaints and other. The questioning is carried out through telephone interviewing by contact center operators and automatic collection of electronic forms through aggregator services.
Treatment:
Behavioral: Communicational program "Trust"

Trial contacts and locations

1

Loading...

Central trial contact

Aleksei Prokhorikhin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems